Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Sine Baoluda Pharmaceutical is a specialized pharmaceutical company based in Shanghai, China, operating as a subsidiary of the Shanghai Sine Pharmaceutical Laboratories under the Shanghai Pharmaceuticals Holding (SPH) group. The company focuses on the development, manufacturing, and commercialization of essential medicines, with a particular emphasis on cardiovascular and gastrointestinal therapies. Its product portfolio includes widely used treatments such as Aspirin Enteric-coated tablets and various gastrointestinal medications. The company maintains modern manufacturing facilities that comply with Good Manufacturing Practice (GMP) standards to ensure high-quality production for the domestic Chinese market. As part of the larger SPH ecosystem, it leverages extensive distribution networks and research resources to maintain its market position in traditional small molecule pharmaceuticals.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Xinyi Baoluda Pharmaceutical.